| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 60.30× | 60.30× | 66.72× | 68.80× | 64.36× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.45× | 1.22× | 1.01× | 1.00× | 0.94× | ||
| 0.76× | 0.76× | 0.68× | 0.66× | 0.63× | ||
| 1.00× | 1.00× | 0.92× | 0.81× | 0.97× | ||
| 0.76× | 0.76× | 0.71× | 0.64× | 0.71× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 64.36 | 68.80 | 66.72 | 60.30 | 60.30 | |
| Working Capital Turnover | 0.94 | 1.00 | 1.01 | 1.22 | 1.45 | |
| Asset Turnover | 0.63 | 0.66 | 0.68 | 0.76 | 0.76 | |
| Cash Conversion (CFO/Net Income) | 0.97 | 0.81 | 0.92 | 1.00 | 1.00 | |
| CFO/EBITDA | 0.71 | 0.64 | 0.71 | 0.76 | 0.76 |